LBA42 Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: The NADINA trial

• DOI: 10.1016/j.annonc.2024.08.2283
• Publication Date: 2024-09-17T21:04:39Z
• Authors: M.W. Lucas; A.M. Menzies; M. Lopez-Yurda; R.A. Scolyer; B. van de Wiel; R.P.M. Saw; W. Van Houdt; N. Maher; A. Torres Acosta; M. Boers-Sonderen; G. Hospers; M.S. Carlino; J.W. de Groot; E. Kapiteijn; K. Suijkerbuijk; P. Rutkowski; S.K. Sandhu; A.A.M. Van der Veldt; G.V. Long; C.U. Blank